<b>Conclusions:</b> Together, these findings demonstrate that NHE1 activity is a critical determinant of migratory capacity in bone sarcoma cells and that CHP2 supports malignant migration and proliferation. The gene discussed is CHP2; the disease is bone sarcoma.